ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    Lymphoid Isolation as an Adjuvant Maneuver for Belatacept-Based Immunotherapy.

    M. Mulvihill,1 K. Samy,2 R. Davis,1 F. Leopardi,1 B. Collins,1 A. Kirk.1

    1Surgery, Duke University Medical Center, Durham, NC; 2Surgery, Indianapolis University Medical Center, Indianapolis, IN

    Purpose: Belatacept targets de novo alloimmune responses with minimal off target effects in renal transplantation, though adjuvant therapy is required for control of costimulation-blockade resistant…
  • 2017 American Transplant Congress

    Impact of Complement Component 3 Single Nuclear Polymorphisms on Renal Transplant Recipients with Antibody-Mediated Rejection.

    Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

    Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

    Impact of complement component 3 single nuclear polymorphisms on renal transplant recipients with antibody-mediated rejectionZijie Wang, Zhijian Han, Jun Tao, Ruoyun Tan, Min GuDepartment of…
  • 2017 American Transplant Congress

    Uromodulin and Toll-Like Receptor 4 Levels Predict Susceptibility to Bacterial Urinary Tract Infection After Renal Transplantation.

    K. Stahl,1 H. Lührs,1 J. Schmitz,2 I. Scheffner,1 W. Gwinner,1 J. Bräsen,2 H. Haller,1 M. Schiffer.1

    1Internal Medicine, Nephrology, Hannover Medical School, Hannover, Germany; 2Pathology, Hannover Medical School, Hannover, Germany

    Background: Urinary tract infection (UTI) remains the most common bacterial infection after kidney transplantation (kTx) and is associated with reduced allograft function as well as…
  • 2017 American Transplant Congress

    Contrast-Induced Acute Kidney Injury in Kidney Transplant Recipients: A Meta-Analysis.

    W. Cheungpasitporn,1 C. Thongprayoon,1 M. Mao,1 S. Mao,2 M. D'Costa,1 W. Kittanamongkolchai,1 K. Kashani.1

    1Nephrology and Hypertension, Mayo Clinic, Rochester, MN; 2Transplantation Surgery, Mayo Clinic, Rochester

    OBJECTIVE: To evaluate the incidence of contrast-induced acute kidney injury (CIAKI) in kidney transplant recipients.METHODS: A literature search was performed using MEDLINE, EMBASE, and the…
  • 2017 American Transplant Congress

    Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID).

    S. Anand,1,3 D. Miller,1 G. Chipman,2 D. Morris,1,3 T. Srinivas.1

    1Intermountain Medical Center, Salt Lake City, UT; 2Utah Cancer Specialists, Salt Lake City, UT; 3Nephrology Assoxiates of Utah, Salt Lake CIty, UT

    Introduction-We report as case of refractory PGNMID treated succesfully with anti-CD38 antibody (Daratumumab). Case report-65 year old male with ESRD attributed to to post infectious…
  • 2017 American Transplant Congress

    Detection of Specific B Cell Memory to the Perlecan LG3 Antigen in the Normal Immune Repertoire.

    L. Padet,1,2,3 M. Dieude,1,2 B. Yang,1,2,3 J. Turgeon,1,2 H. Cardinal,1,2 M.-J. Hebert.1,2,3

    1Research Center of Montreal Hospital Center (CRCHUM), Montreal, Canada; 2Canadian National Transplant Research Program (CNTRP), Edmunton, Canada; 3Université de Montréal, Montreal, Canada

    Autoantibodies targeting the C-terminal fragment of perlecan (LG3) were identified in patients with kidney transplantation and are associated with rejection episodes. High anti-LG3 titers were…
  • 2017 American Transplant Congress

    Warm Ischemic Time as an Additive Predictor of Graft Survival in KDPI/KDRI Era of Kidneys from Donors After Cardiac Death: A Single-Center Experience Over Three Decades.

    M. Kusaka,1 Y. Kubota,1 H. Takahashi,2 H. Sasaki,1 M. Takenaka,1 N. Fukami,1 T. Kenmochi,3 R. Shiroki,1 K. Hoshinaga.1

    1Urology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Division of Medical Statistics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 3Organ Transplant Surgery, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

    It is important to predict the outcome of grafts prior to kidney transplantation and establish an appropriate allocation system, particularly to consider expanded criteria donors…
  • 2017 American Transplant Congress

    Access to Living Donor Kidney Transplantation in Nepal.

    P. Shrestha,1 S. Rasmussen,1 A. Thomas,1 S. Ferguson,2 A. Massie,1 D. Segev,1 P. Shrestha.3

    1JHU, Baltimore; 2Grinnell College, Grinnell; 3Human Organ Transplant Center, Bhaktapur, Nepal

    Kidney transplantation is a relatively new and rapidly growing treatment modality in Nepal. Disparities in access to care are greatly amplified in a developing country…
  • 2017 American Transplant Congress

    Malignancy in Patients Undergoing Simultaneous Heart-Liver and Heart-Kidney Transplant.

    A. Chin, A. Habertheuer, A. Chou, M. Acker, M. Williams, P. Atluri, C. Bermudez, P. Vallabhajosyula.

    University of Pennsylvania, Philadelphia, PA

    Purpose: While evidence suggests that patients undergoing simultaneous heart-liver and heart-kidney transplant may have improved immunoprotection from allograft rejection versus patients undergoing heart transplant only,…
  • 2017 American Transplant Congress

    Titers of Blood Group B Patients Using Non-A1 Reagent/Donor Cells for the Purpose of ABO Incompatible Kidney Transplantation.

    D. King, M. Aguilucho, M. Marchioni, B. Figueiredo, I. Okere, P. Rao.

    NJ Sharing Network, New Providence

    Background: Blood group B patients are eligible to receive offers from non-A1 or non-A1B kidney donors. Current practice in many institutions involves performing these titers…
  • « Previous Page
  • 1
  • …
  • 379
  • 380
  • 381
  • 382
  • 383
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences